European Companies Search Engine
EU funding (€1,999,784): European consortium for communicating gene- and cell-based therapy information. Hor1 Feb 2021 EU Research and Innovation programme "Horizon"
Overview
Text
European consortium for communicating gene- and cell-based therapy information.
The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) unites 49 partner organisations and institutions across Europe, including the major European advanced therapies learned societies, with the common goal of providing reliable and accessible information related to cell and gene therapy development to European stakeholders. EuroGCT has two major objectives: • To provide patients, people affected by conditions, healthcare professionals and citizens with accurate scientific, legal, ethical and societal information and with engagement opportunities, and thus to support better informed decision-making related to cell and gene-based therapies. • To facilitate better decision-making at key points in development of new therapies and thus enable improved product development, by providing the research community and regulatory and healthcare authorities with an information source on the practical steps needed for cell and gene therapy development. To achieve our aims, EuroGCT will adopt a highly structured system for coordinated management of information related to cell and gene therapy development and, from this, will implement an ambitious programme of online and direct stakeholder information provision and engagement. All outputs will be delivered in 7 European languages, to ensure broad accessibility, and will be rigorously evaluated against measurable objectives throughout the project duration. The proposed consortium comprises leading cell and gene therapy-related organisations and basic and clinical research labs across Europe, including new member states; together with experts in product development, ethical, legal and societal issues, and in evaluating clinical outcomes; patient representatives; and science communicators. It thus is uniquely placed to develop a world-leading cell and gene therapy information resource and to meet the challenge outlined in Topic SC1-HCO-19-2020.
Funded Companies:
| Company name | Funding amount |
| Academisch Ziekenhuis Groningen | €0.00 |
| Academisch Ziekenhuis Leiden | €0.00 |
| €0.00 | |
| BUNDESINSTITUT für IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL | €0.00 |
| Biotalentum Tudasfejleszto kft. | €0.00 |
| Cardiff University | €0.00 |
| Cell Therapy Catapult Ltd. | €0.00 |
| €0.00 | |
| ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE | €0.00 |
| EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH | €0.00 |
| Ecrin European Clinical Research Infrastructure Network | €0.00 |
| FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. | €0.00 |
| €0.00 | |
| €0.00 | |
| GERMAN STEMCELL NETWORK (GSCN) - DEUTSCHES STAMMZELLNETZWERK e. V. | €0.00 |
| HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM für GESUNDHEIT UND UMWELT GmbH | €0.00 |
| ITA-SUOMEN YLIOPISTO | €0.00 |
| Imperial College of Science Technology and Medicine | €0.00 |
| Institut Pasteur | €0.00 |
| €0.00 | |
| Karolinska Institutet | €0.00 |
| King's College London | €0.00 |
| Kobenhavns Universitet | €0.00 |
| Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw | €0.00 |
| Lunds Universitet | €0.00 |
| MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN e. V. | €0.00 |
| Masarykova Univerzita | €0.00 |
| Queen Margaret University, Edinburgh | €0.00 |
| STAMMZELLNETZWERK.NRW e. V. | €0.00 |
| €0.00 | |
| The Chancellor Masters and Scholars of the University of Cambridge | €0.00 |
| The University of Edinburgh | €1,710,484 |
| €0.00 | |
| The University of Manchester | €0.00 |
| €0.00 | |
| UNIVERSITAETSKLINIKUM FREIBURG | €0.00 |
| €0.00 | |
| €0.00 | |
| Universita Degli Studi DI Milano | €0.00 |
| Universita Degli Studi DI Modena E Reggio Emilia | €0.00 |
| Universitaet Innsbruck | €0.00 |
| Universite Libre de Bruxelles | €0.00 |
| Universite d'AIX Marseille | €289,300 |
| €0.00 | |
| Uniwersytet Jagiellonski | €0.00 |
| Uniwersytet Warszawski | €0.00 |
| Vrije Universiteit Brussel | €0.00 |
Source: https://cordis.europa.eu/project/id/965241
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "Academisch Ziekenhuis Groningen - EU funding (€1,999,784): European consortium for communicating gene- and cell-based therapy information."
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
